Moderna, Inc.
MRNA institutional ownership changes in Q2 2026: 151 institutions opened or added positions, 115 trimmed or exited. MRNA (Moderna, Inc.) is held by 258 institutional investors as of Q2 2026. Top institutional shareholders: FMR LLC ($3.6B), BlackRock, Inc. ($2.1B), Vanguard Capital Management LLC ($1.6B). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Oct 16, 2026 · Activists Nov 5, 2026 · Congress Oct 7, 2026
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 51.9M(+13.6%) | $3.6B | 0.2% | +292.13% | 43 | |
Increased | 30.6M(+3.3%) | $2.1B | 0.0% | +289.42% | 33 | |
Increased | 23.2M(+1.5%) | $1.6B | 0.0% | +347.23% | 32 | |
Increased | 22.3M(+19.1%) | $1.6B | 0.2% | +448.89% | 45 | |
Decreased | 18.2M(-8.9%) | $1.3B | 1.2% | +88.34% | 0 | |
Increased | 15.7M(+5.8%) | $1.1B | 0.0% | +27.70% | 34 | |
Decreased | 15.6M(-0.2%) | $1.1B | 0.0% | +349.69% | 0 | |
Increased | 9.7M(+2.9%) | $678.8M | 0.0% | +67.46% | 33 | |
Increased | 9.5M(+12.6%) | $668M | 0.0% | +270.24% | 36 | |
Decreased | 7.2M(-20.8%) | $503.8M | 0.4% | +552.47% | 0 | |
Increased | 5.8M(+20.8%) | $404.8M | 0.0% | +186.86% | 37 | |
Increased | 5.6M(+656.8%) | $391.4M | 0.0% | +211.94% | 50 | |
Increased | 4.8M(+2.2%) | $338.9M | 0.0% | +134.81% | 32 | |
Decreased | 4.7M(-29.3%) | $327.2M | 0.0% | +155.66% | 0 | |
Increased | 4.5M(+1.3%) | $312.6M | 0.0% | +315.95% | 31 | |
Increased | 4.4M(+1.4%) | $306.5M | 0.1% | +355.61% | 37 | |
Increased | 3M(+1.1%) | $209.1M | 0.0% | +40.79% | 31 | |
Decreased | 2.7M(-1.8%) | $189M | 1.2% | +197.91% | 0 | |
Increased | 2.5M(+15.8%) | $172.9M | 0.0% | +198.30% | 35 | |
Increased | 2.5M(+4.4%) | $172.4M | 0.0% | +337.66% | 32 |
Showing 1-20 of 272
| Insider | Trade | Traded |
|---|---|---|
| Hoge Stephen | Exercise 76K sh | |
| Hoge Stephen | Sell $8.6M | |
| Hoge Stephen | Exercise 76K sh | |
| Hoge Stephen | Sell $96K | |
| Hoge Stephen | Sell $8.3M | |
| Mock James M | Exercise 1K sh | |
| Mock James M | Tax 704 sh | |
| Hoge Stephen | Sell $5.9M | |
| Hoge Stephen | Exercise 76K sh | |
| Hoge Stephen | Exercise 76K sh |
| Member | Trade | Traded |
|---|---|---|
| Maria Elvira Salazar | Sale $1,001 - $15,000 | |
| Maria Elvira Salazar | Buy $1,001 - $15,000 | |
| Maria Elvira Salazar | Sale $1,001 - $15,000 | |
| Rob Bresnahan | Sale $1,001 - $15,000 | |
| Rob Bresnahan | Buy $1,001 - $15,000 | |
| Julie Johnson | Sale $1,001 - $15,000 | |
| Josh Gottheimer | Sale $1,001 - $15,000 |
| Filer | Stake | Filed |
|---|---|---|
| FMR LLC | 14.8% | |
| Capital World Investors | 5.6% | |
| FMR LLC | 13.1% | |
| BAILLIE GIFFORD & CO | 4.6% | |
| Vanguard Capital Management | 6.5% | |
| The Vanguard Group | 0.0% | |
| BAILLIE GIFFORD & CO | 5.3% | |
| FMR LLC | 10.6% |
MRNAModerna, Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about MRNA
Who owns MRNA?
258 institutional investors held MRNA on June 30, 2026, led by FMR LLC ($3.6B), BlackRock, Inc. ($2.1B) and Vanguard Capital Management LLC ($1.6B).
How many hedge funds hold MRNA?
258 institutional investors reported MRNA in their 13F filings for the quarter ended June 30, 2026, $20.4B in all. 13 of them are rated Elite.
Are institutions buying or selling MRNA?
Buying, on balance. In Q2 2026, 151 institutions opened or added to positions in MRNA and 115 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer